
Bioorganic and Medicinal Chemistry p. 1327 - 1337 (1997)
Update date:2022-07-29
Topics:
Mu, YongQi
Gibbs, Richard A.
A novel strategy for the generation of aldolase catalytic antibodies, based on the use of antibody-catalyzed enol ester hydrolysis as a 'trigger' to generate a reactive enolate intermediate, is described. A model system to test this strategy was developed and substrate 8 was synthesized. However, the targeted bifunctional haptens 11 and 33 were synthetically inaccessible, and therefore the alternative phosphonate hapten 39 was prepared. The key step in the synthesis of 39 was the direct generation of an unprotected phosphonate precursor via coupling of the secondary alcohol 37 with CH3P(O)CI2. The chiral counterpart of hapten 39 was also synthesized from alcohol 46, prepared by Corey's asymmetric reduction method. One polyclonal antibody preparation generated from 39 appeared to catalyze the hydrolysis of the secondary acetate 49, but not the desired aldol cyclization of 8. Possible rationales for this finding are discussed.
View MoreFREEBARQUE DEVELOPMENT GROUP LIMITED
Contact:+86(0)10-5109 5335 or 5109 5345
Address:Room602,Block1-B,LINGDI OFFICE,NO.13 BEIYUAN ROAD
Frapp's Chemical (NFTZ) Co.,Ltd
Contact:+86-576-86137892
Address:General Chamber of Commercial Building, 159 Wanchang Middle Road, Wenling, Zhejiang, China
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Contact:+91 9963263336
Address:Plot#146A, IDA Mallapur, Hyderabad - 500072
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Doi:10.1073/pnas.1904700116
(2019)Doi:10.1002/anie.201706794
(2017)Doi:10.1021/om000048l
(2000)Doi:10.1039/c5ra25854e
(2016)Doi:10.1002/hlca.19810640719
(1981)Doi:10.1248/cpb.13.1445
(1965)